Pulse - Double Trouble: Antipsychotics in the Treatment of Antipsychotic-Induced Hyperprolactinemia
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Pharmacists need to understand the treatment options, including limitations and benefits, for antipsychotic induced hyperprolactinemia.
Target Audience
Pharmacist
Learning Objectives
Describe antipsychotic induced hyperprolactinemia, including proposed etiology and clinical manifestations
Identify the limitations and benefits of treatment options for antipsychotic induced hyperprolactinemia
Discuss the role of second and third generation antipsychotics as potential treatments for antipsychotic induced hyperprolactinemia
Additional Information
Attachment | Size |
---|---|
![]() | 216.14 KB |
![]() | 16.93 KB |
New medications and new guidelines are constantly being released. Pharmacists need a mechanism to keep up with these new medications and guidelines.
Pharmacists need to understand the treatment options, including limitations and benefits, for antipsychotic induced hyperprolactinemia.
Emily Thacker, PharmD
PGY1 Pharmacy Resident
UPMC Western Psychiatric Hospital
In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit.
Available Credit
- 1.00 ACPE PharmacyThe UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.